Showing results (1821-1830 of 1,881) with videos related to

Sort By:
Pageof 189
Immunotherapy|December 6, 2023
Molecular interactions of antibodies with PD-1/PD-L1 proteinsSofia Vasilakaki, Ioannis Vathiotis, Emmanouil Panagiotou, et al.
Immunotherapy|March 15, 2024
Outcomes for pembrolizumab stratified by pemetrexed maintenance post pembrolizumab-platinum-pemetrexed induction in metastatic non-small-cell lung cancerJerome H Goldschmidt, Srinivas Annavarapu, Divea Venkatasetty, et al.
Immunotherapy|February 29, 2024
Association between sex and efficacy of immune checkpoint inhibitors: a systematic review and meta-analysisJianxiong Lai, Xiaohong Kuang, Yi Fu, et al.
Immunotherapy|April 5, 2024
Prognostic value of peripheral blood neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, pan-immune-inflammation value and systemic immune-inflammation index for the efficacy of immunotherapy in patients with advanced gastric cancerMaodong Fu, Xiuping Zhang, Feng Shen, et al.
Immunotherapy|June 18, 2024
Pembrolizumab in an HIV-infected patient with glioblastomaCarlen A Yuen, Silin Bao, Melike Pekmezci, et al.
Immunotherapy|November 7, 2023
Immune checkpoint inhibitor-associated hemophagocytic lymphohistiocytosis in a patient with chronic lymphocytic leukemiaSyed B Ali, Bryone Kuss, Chris Karapetis, et al.
Immunotherapy|October 12, 2023
Integrase inhibitors: current protagonists in antiretroviral therapyJohn D Loaiza, Mateo Chvatal-Medina, Juan C Hernandez, et al.
Immunotherapy|October 16, 2023
Secukinumab in the treatment of hidradenitis suppurativaCorey L Snyder, Ruby S Gibson, Martina L Porter, et al.
Immunotherapy|September 29, 2023
Tezepelumab for the treatment of severe asthma: a plain language summary of the PATHWAY and NAVIGATOR studiesJonathan Corren, Andrew Menzies-Gow, Johan Bimmel, et al.
Immunotherapy|September 20, 2023
Safety and effectiveness of a 300 IR house dust mite sublingual tablet: descriptive 4-year final analysis of a post-marketing surveillance in JapanYoshitaka Okamoto, Moe Kato, Kiyonori Ishii, et al.
Pageof 189